Immunogen, Inc.

ELAHERE

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ELAHERE – J9063

Manufacturer:

Immunogen, Inc.

Name:

ELAHERE

HCPCS Code Descriptor:

Injection, mirvetuximab soravtansine-gynx, 1 mg

Category:

J Code

HCPCS:

J9063

NDC(s):

72903-0853-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ELAHERE is a Oncology drug manufactured by Immunogen, Inc. and administered via the Intravenous route of administration. The J Code: J9063 is aligned to the drug ELAHERE.

ELAHERE is a cancer medication under the class of medications known as antineoplastics monoclonal antibody. It works by slowing down and killing the cancer cells. ELAHERE can be used to treat certain types of ovarian cancer, fallopian tube cancer, and peritoneal cancer. This drug is manufactured by Immunogen and is aligned to the HCPCS code J9063.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/23

HCPCS Effective Date:

7/1/23

HCPCS Short Description:

Inj, elahere, 1 mg

Billing and Coding Guide:

https://www.elaherehcp.com/pdf/elahere-billing-and-coding-guide.pdf

Patient Assistance:

Not Found

ELAHERE - J9063